Lung Cancer
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.3 | Q1 | 86.0% | 1.928 | Q1 | 94.9% |
| 2024 | 4.4 | Q1 | 83.3% | 1.752 | Q1 | 94.1% |
| 2023 | 4.5 | Q1 | 81.7% | 1.761 | Q1 | 94.5% |
| 2022 | 5.3 | Q2 | 82.8% | 1.609 | Q1 | 93.8% |
| 2021 | 6.1 | Q1 | 85.6% | 1.399 | Q1 | 92.2% |
| 2020 | — | — | 1.989 | Q1 | 95.6% | |
| 2019 | — | — | 1.705 | Q1 | 94.1% | |
| 2018 | — | — | 1.905 | Q1 | 94.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1872-8332
ISSN
0169-5002
country
IEcoverage
1985-2026